“This is the year of innovation for China”: Danone to beef up infant formula, FSMP range By Tingmin Koe 03-Sep-2024 - Last updated on 03-Sep-2024 at 06:09 GMT Facebook Twitter Linkedin Email to a friend Danone is doubling down on its specialised nutrition offerings, including infant formula and Foods for Special Medical Purposes (FSMP) for China, a market which it said has delivered “stellar performance” for the first half of 2024.Read the full story here. NIA top stories monthly “This is the year of innovation for China”: Danone to beef up infant formula, FSMP range Hong Kong nutra trends: NMN booming and strategies to meet local and Chinese visitors’ needs Novel format, celebrity push, and German branding key for Korea success – Orthomol BYHEALTH cites tough market conditions for nearly 18% revenue decline Sleep, mental health underlined as top-of-mind concerns among APAC consumers amid cost-of-living crisis Fonterra delves deeper into protein and phospholipids for mobility-related innovations to combat Asia’s ageing population Calcium supplements: China consumers resonate strongly with absorption benefits, says Haleon NMN measurements: China drafts industry standards to assess cross-border e-commerce products 'Proof on the front': Indian start-up ReNewtra adopts front-of-pack labelling as concerns over transparency grow Kirin plans to acquire another overseas asset if FANCL deal fails Prev 1 2 3 4 5 … 11 Next
